Exploring the Feasibility, Acceptability, and Safety of a 4:3 Intermittent Fasting Weight Loss Program Among Stage I-III Breast Cancer Survivors With Overweight or Obesity: Protocol for a 6-Month Proof-of-Concept Feasibility Trial

Exploring the Feasibility, Acceptability, and Safety of a 4:3 Intermittent Fasting Weight Loss Program Among Stage I-III Breast Cancer Survivors With Overweight or Obesity: Protocol for a 6-Month Proof-of-Concept Feasibility Trial

Authors of this article:

Katrina M Oselinsky^{1, 2, 3} ;   Emily B Hill^{2, 3, 4} ;   Danielle M Ostendorf^{1, 5} ;   Zhaoxing Pan^{2, 6} ;   Kristen Bing² ;   Liza T Wayland² ;   Chloe Simpson² ;   Kevin C Clark² ;   Anaeli Sandoval² ;   Elizabeth A Thomas^{1, 2, 7, 8} ;   Ryan J Marker^{2, 3, 9} ;   Peter Kabos^{3, 10} ;   Paul S MacLean^{1, 2, 3} ;   Victoria A Catenacci^{1, 2, 3}